Quick Answer
RIGEL PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 18.31 million shares for the year ending 2025.
- RIGEL PHARMACEUTICALS INC showed an increase of +3.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from RIGEL PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), RIGEL PHARMACEUTICALS INC's Common Stock Shares Outstanding has declined by 65.0%.
- Historical annual values: Fiscal year 2025: 18.31 million shares | Fiscal year 2024: 17.71 million shares | Fiscal year 2023: 17.48 million shares | Fiscal year 2022: 173.40 million shares | Fiscal year 2021: 171.60 million shares | Fiscal year 2020: 169.32 million shares | Fiscal year 2019: 167.99 million shares | Fiscal year 2018: 167.17 million shares | Fiscal year 2017: 146.81 million shares | Fiscal year 2016: 99.27 million shares | Fiscal year 2015: 90.55 million shares | Fiscal year 2014: 88.04 million shares | Fiscal year 2013: 87.52 million shares | Fiscal year 2012: 87.14 million shares | Fiscal year 2011: 71.38 million shares | Fiscal year 2010: 52.27 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: